[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609768":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":33,"responsibleParty":51,"collaborators":54,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":60,"sex":65,"minAge":66,"maxAge":20,"enrollmentInfo":67,"targetDuration":20,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":78,"overallStatus":36,"whyStopped":20,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"University of Pittsburgh","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Symptom monitoring via smartphone app","EXPERIMENTAL","Participants will rate symptoms daily for 90 days using PRO-CATCAE questions to assess 8 common chemotherapy-related symptoms. Participants will wear a Fitbit (Inspire 3 or similar) for the duration of the study and install the Fitbit app on their smartphone. The Fitbit is a wristwatch-sized waterproof device that assesses heart and breathing rates, physical activity, and sleep, skin temperature, and oxygen levels and wirelessly transmits data to the server.",[13],"Behavioral: Mobile Symptom Monitoring and Alert App",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BEHAVIORAL","Mobile Symptom Monitoring and Alert App","Responses range from 0-4; any grade 1 response (reflecting mild symptoms) will trigger a recommendation to view symptom management\u002Feducation tips available in a self-care library in the app, and any grade 2-4 response (reflecting moderate to severe symptoms) will trigger a recommendation that the participant may want to contact their provider about the potentially concerning symptom. Fitbit data points outside of prespecified thresholds based on physiological norms (for skin temperature and pulse oxygenation) or each participants' historic average (heart rate and activity) will trigger a recommendation that the participant may want to contact their provider about the potentially concerning data point. Reports will be generated and emailed to participants each week displaying summaries\u002Fgraphs of recent alerts triggered, symptom ratings, and Fitbit data.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Carissa A Low","PRINCIPAL_INVESTIGATOR",[26,30],{"name":23,"role":27,"phone":28,"phoneExt":20,"email":29},"CONTACT","(412) 623-5973","lowca@upmc.edu",{"name":31,"role":27,"phone":20,"phoneExt":20,"email":32},"Krina C Durica","duricak@upmc.edu",[34],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"UPMC Hillman Cancer Center","RECRUITING","Pittsburgh","Pennsylvania","15232","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-79.99589,40.44062,{"lat":46,"lon":45},[49,50],{"name":23,"role":27,"phone":28,"phoneExt":20,"email":29},{"name":23,"role":24,"phone":20,"phoneExt":20,"email":20},{"type":24,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Carissa Low","Associate Professor",[55],{"name":56,"class":57},"National Cancer Institute (NCI)","NIH","100609768","feasibility-and-acceptability-of-the-remote-oncology-symptom-assessment-application-100609768",false,"NCT07218874","Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application","ROSA App","Inclusion Criteria:\n\n* Receiving chemotherapy at the UPMC Hillman Cancer Center for any solid tumor cancer at any stage with at least two cycles remaining;\n* age 18 years or older;\n* ability to read and write in English;\n* sufficient performance status to participate in research (e.g., Karnofsky performance status of 60-100%); and\n* owns and uses an Android smartphone or an iPhone capable of running the study apps.\n\nExclusion Criteria:\n\n* under 18 years old; and\n* unable to read and write in English","ALL","18 Years",{"count":68,"type":69},50,"ESTIMATED","INTERVENTIONAL",[72],"NA","The goal of this study is to determine whether a mobile application that combines real-time sensor data and patient-reported symptoms to trigger care-team contact recommendations is feasible and beneficial for patients receiving chemotherapy. The main questions it aims to answer are:\n\n* Is the mobile application feasible and acceptable to patients?\n* Do the alerts and guidance improve symptom management, quality of life, and engagement with the care team during treatment?\n\nParticipants will:\n\n* Complete a demographic questionnaire at the beginning of the study and quality-of-life and health questionnaires at the beginning, midpoint, and end of study.\n* Complete daily symptom ratings.\n* Wear a Fitbit activity tracker for 90 days.\n* At the end of the study, complete a semi-structured interview to provide feedback on the study.\n* Optional: At the beginning and end of the study, complete an in-person physical function assessment measuring balance (Short Physical Performance Battery).",[75,76,77],"Cancer","Solid Tumor Cancer","Chemotherapy",[79,80,81],"quality of life","symptom management","smartphone application","2026-02-02",{"date":84,"type":85},"2026-02-04","ACTUAL",{"date":82,"type":85},{"date":88,"type":69},"2026-12-31",{"name":5,"class":6},1]